EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.108
March 31, 2026 -0.1001
December 31, 2025 -0.0842
September 30, 2025 -0.1708
June 30, 2025 -0.157
March 31, 2025 -0.1053
December 31, 2024 -0.2264
September 30, 2024 -0.1778
June 30, 2024 -0.1627
March 31, 2024 -0.1374
December 31, 2023 -0.1557
September 30, 2023 -0.1746
June 30, 2023 -0.1807
Date Value
March 31, 2023 -0.1683
December 31, 2022 -0.237
September 30, 2022 -0.2273
June 30, 2022 -0.2332
March 31, 2022 -0.2537
December 31, 2021 -0.2142
September 30, 2021 -0.1326
June 30, 2021 -3.052
March 31, 2021 -2.131
December 31, 2020 -1.775
September 30, 2020 -0.579
June 30, 2020 -1.532

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. -0.0306
Medpace Holdings, Inc. 4.250
Avantor, Inc. 0.0563
Personalis, Inc. -0.3005
Adaptive Biotechnologies Corp. -0.2489